معرفی
Dr. Kenneth Bader is an Associate Professor in the Department of Radiology at the University of Chicago's Pritzker School of Medicine. He leads the Biomedical Acoustics Development and Engineering Research Laboratory (BADER Lab), focusing on translating therapeutic ultrasound into clinical applications for non-invasive treatment of cardiovascular and cancerous diseases. His work bridges physics, engineering, and medicine, with emphasis on developing innovative ultrasound-based therapies.
- Education: B.S. in Physics from Grand Valley State University (2005), Ph.D. in Physics from the University of Mississippi (2011)
- Current Funding: Principal Investigator on two major NIH R01 grants (R01EB035230 and R01HL133334) totaling nearly a decade of continuous research support
- Lab Affiliation: BADER Lab (baderlab.uchicago.edu)
Dr. Bader's research centers on acoustic cavitation and histotripsy for combinatorial ablation and enhanced drug delivery strategies targeting pathologies resistant to standard interventions. He develops multi-modal imaging approaches combining diagnostic ultrasound and magnetic resonance imaging to assess bubble activity and resultant tissue changes. His work spans fundamental bubble dynamics modeling to translational applications in thrombosis and cancer treatment. Key areas include chronic thrombus ablation, histotripsy-enhanced drug delivery, sonochemical reactions for cancer therapy, and MR-guided transurethral prostate ablation.
His publication record demonstrates consistent productivity with over 40 publications since 2012, showing an upward trajectory with 25 publications in the last five years (2020-2025). His work appears in high-impact journals including IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control; Physics in Medicine & Biology; and Journal of Ultrasound in Medicine. His research shows strong interdisciplinary collaboration across engineering, physics, radiology, and vascular medicine.
Dr. Bader serves as Principal Investigator on two major NIH-funded projects: Imaging Feedback for Histotripsy Renal Tumor Ablation (2024-2028) and Treatment of chronic venous thrombosis with histotripsy and thrombolytics (2017-2028). These projects represent significant sustained funding for developing ultrasound-based therapies for cancer and vascular diseases. His work has generated substantial interest in the scientific community, with multiple publications receiving over 50 citations, particularly his foundational work on bubble dynamics in histotripsy.
The BADER Lab represents a hub for ultrasound research at the University of Chicago, developing both theoretical models and practical applications of therapeutic ultrasound. The lab focuses on translating laboratory discoveries into clinical practice, with particular emphasis on making treatments more effective while minimizing invasiveness. Current work includes developing AI approaches for ultrasound image analysis, novel transducer designs, and combination therapies that leverage both mechanical and biochemical effects of ultrasound.
